Fatigue and Kinematics During Isometric Activity of the Upper Limbs in Young and Older Adults

March 30, 2022 updated by: Helena Silva, Escola Superior de Saude da Cruz Vermelha Portuguesa - Lisboa

Relationship Between Perceive Effort, Physiological and Kinematic Changes During Upper Limbs Isometric Activity and Its Relationship With the Socio-demographic Characteristics

The aim of this study is to understand the relationship between perceived effort and physiological and kinematic variables caused by isometric activity of the upper limbs, as well as its relationship with socio-demographic characteristics, level of activity and quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lisboa, Portugal, 1300-125
        • Escola Superior de Saúde da Cruz Vermelha Portuguesa - Lisboa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy
  • Minimum age of 18 years;

Exclusion Criteria:

  • Unable to provide written consent
  • History of heart, cardiovascular and / or respiratory disease,
  • Known untreated hypertension, cardiomyopathy, or exercise intolerance
  • Presence of cognitive or neurological disorders
  • Neuromuscular or orthopaedic disorder that limits the movement of the upper limb to 90° flexion or the maintenance of that position
  • BMI ≥ 40

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Isometric activity
All participants will be included in this arm
Participants will do elevation of upper limbs and mantain a 90º degree flexion position in an unsupported way.
Other Names:
  • Isometric task

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in perceived effort on the Borg category-ratio 10-point scale (CR 10)
Time Frame: From baseline to end of activity, up to 15 minutes
The perceived effort will be measured with Borg CR 10 scale. Possible scores range from 0 (no exertion at all) to 10 (extremely strong).
From baseline to end of activity, up to 15 minutes
Change from Baseline in heart rate
Time Frame: From baseline to end of activity, up to 15 minutes
Heart rate (heart beatings per minute) measured before and during activity to track cardiovascular changes during activity.
From baseline to end of activity, up to 15 minutes
Change from Baseline in respiratory rate
Time Frame: From baseline to end of activity, up to 15 minutes
Respiratory rate (respiratory cycles per minute) measured before and during activity to track changes in respiratory function during activity.
From baseline to end of activity, up to 15 minutes
Change from Baseline in heart rate variability (HRV)
Time Frame: From baseline to end of activity, up to 15 minutes
Interval (in milliseconds) between consecutive heartbeats measured before and during activity to track changes in autonomic function during activity.
From baseline to end of activity, up to 15 minutes
Change from Baseline in electrodermal activity (EDA)
Time Frame: From baseline to end of activity, up to 15 minutes
Electrical conductance (in microsiemens -µS) between two points of the hand over time measured before and during activity to track changes in autonomic function during activity.
From baseline to end of activity, up to 15 minutes
Change from Baseline in muscle action potential amplitude through surface electromyography (sEMG)
Time Frame: From baseline to end of activity, up to 15 minutes
Muscle action potential amplitude (in millivolts - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
From baseline to end of activity, up to 15 minutes
Change from Baseline in muscle action potential duration through surface electromyography (sEMG)
Time Frame: From baseline to end of activity, up to 15 minutes
Muscle action potential duration (in milliseconds - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
From baseline to end of activity, up to 15 minutes
Change from Baseline in muscle action potential frequency through surface electromyography (sEMG)
Time Frame: From baseline to end of activity, up to 15 minutes
Muscle action potential frequency (in hertz - Hz) of surface electromyographic signal measured before and during activity to track muscular fatigue signs.
From baseline to end of activity, up to 15 minutes
Change from Baseline in respiratory pattern through inertial motion units (IMU) from baseline and during activity
Time Frame: From baseline to end of activity, up to 15 minutes
Angular range of motion (in degrees) of rib cage and abdominal wall during upper limb activity measured before and during activity to track changes in respiratory pattern during activity
From baseline to end of activity, up to 15 minutes
Change from Baseline in upper limb motion angular acceleration through inertial motion units (IMU) system
Time Frame: From baseline to end of activity, up to 15 minutes
Angular acceleration (in m/s^2) of the arm measured before and during activity to track small movements of upper limb during isometric activity
From baseline to end of activity, up to 15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Status
Time Frame: Before isometric activity
Health Status will be measured with Medical Outcomes Study (MOS) Short Form Health Survey 36 Item version 2 which measure health status of populations and individuals. Possible scores range from 0 0 (worst health status) to 100 (best health status).
Before isometric activity
Physical activity level
Time Frame: Before isometric activity

Physical activity level will be measured using European Prospective Investigation into Cancer and Nutrition Physical Activity Questionnaire (EPIC-PAQ) that allows to estimate energy expenditure through self-report assessment of the intensity and average duration (per day, week and month) of physical activity performed by the participants in three distinct dimensions (professional, domestic and leisure).

Participants are classified as ACTIVE if they perform: at least 150 minutes per week of moderate physical activity; OR at least 75 minutes per week of vigorous physical activity; OR at least 150 minutes per week of a combination of moderate-intensity activity. If they don't present any of the conditions described, they will be categorized as SEDENTARY.

Before isometric activity

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Daniel López López, PhD, Universidade da Coruña

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

February 28, 2022

Study Completion (Actual)

February 28, 2022

Study Registration Dates

First Submitted

June 4, 2021

First Submitted That Met QC Criteria

June 16, 2021

First Posted (Actual)

June 24, 2021

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 30, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ESSCVP_FIS01/2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Isometric activity

3
Subscribe